Skip to main content

Table 3 Prevalence of all mutation

From: The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients

Mutation % in whole series (%)
Overall mutational rate 60.2
NPM1 38.7
FLT3-ITD 24.5
c-KIT 48.4
N-RAS 25.8
IDH1 9.6
FLT3-TDK 5.1
IDH2 19.3
DNMT3A 9.6
WT1 12.9
RUNX1 9.6
TET2 0
ASXL1 0
WT1 high (expression) 84.6